Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Bridoux

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Blood|December 14, 2023
Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case seriesNathalie Forgeard, Dikélélé Elessa, Alexander Carpinteiro, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 6, 2016
Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up studyAntoine Thierry, Yannick Le Meur, Laure Ecotière, et al.
Kidney International|June 24, 2020
New clinical forms of hereditary apoA-I amyloidosis entail both glomerular and retinal amyloidosisMagali Colombat, Jean-Claude Aldigier, Pierre-Raphael Rothschild, et al.
Kidney International|September 26, 2025
Revisiting proliferative glomerulonephritis with monoclonal immunoglobulin deposits through immunoglobulin repertoire sequencingVincent Javaugue, Virginie Pascal, Samih H Nasr, et al.
Blood|February 29, 2020
A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosisMurielle Roussel, Giampaolo Merlini, Sylvie Chevret, et al.
Blood|June 20, 2020
Immunoglobulin light-chain toxicity in a mouse model of monoclonal immunoglobulin light-chain deposition diseaseSébastien Bender, Maria Victoria Ayala, Amélie Bonaud, et al.
Kidney International|April 17, 2019
Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disordersVincent Javaugue, Céline Debiais-Delpech, Mathilde Nouvier, et al.
Kidney International|January 11, 2017
The clinicopathologic characteristics of kidney diseases related to monotypic IgA depositsMarguerite Vignon, Camille Cohen, Stanislas Faguer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 2, 2022
Diagnosis and risk factors for intracranial aneurysms in autosomal polycystic kidney disease: a cross-sectional study from the Genkyst cohortSiriane Lefèvre, Marie-Pierre Audrézet, Jean-Michel Halimi, et al.
Blood Cancer Journal|August 18, 2022
Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research GroupAndrea Havasi, Cihan Heybeli, Nelson Leung, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Blood|December 14, 2023
Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case seriesNathalie Forgeard, Dikélélé Elessa, Alexander Carpinteiro, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 6, 2016
Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up studyAntoine Thierry, Yannick Le Meur, Laure Ecotière, et al.
Kidney International|June 24, 2020
New clinical forms of hereditary apoA-I amyloidosis entail both glomerular and retinal amyloidosisMagali Colombat, Jean-Claude Aldigier, Pierre-Raphael Rothschild, et al.
Kidney International|September 26, 2025
Revisiting proliferative glomerulonephritis with monoclonal immunoglobulin deposits through immunoglobulin repertoire sequencingVincent Javaugue, Virginie Pascal, Samih H Nasr, et al.
Blood|February 29, 2020
A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosisMurielle Roussel, Giampaolo Merlini, Sylvie Chevret, et al.
Blood|June 20, 2020
Immunoglobulin light-chain toxicity in a mouse model of monoclonal immunoglobulin light-chain deposition diseaseSébastien Bender, Maria Victoria Ayala, Amélie Bonaud, et al.
Kidney International|April 17, 2019
Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disordersVincent Javaugue, Céline Debiais-Delpech, Mathilde Nouvier, et al.
Kidney International|January 11, 2017
The clinicopathologic characteristics of kidney diseases related to monotypic IgA depositsMarguerite Vignon, Camille Cohen, Stanislas Faguer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 2, 2022
Diagnosis and risk factors for intracranial aneurysms in autosomal polycystic kidney disease: a cross-sectional study from the Genkyst cohortSiriane Lefèvre, Marie-Pierre Audrézet, Jean-Michel Halimi, et al.
Blood Cancer Journal|August 18, 2022
Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research GroupAndrea Havasi, Cihan Heybeli, Nelson Leung, et al.
Pageof 17